Quantification of FITC extracted from the tumour, tumour-draining lymph nodes (TDLNs), and other distal tissues 24 h post injection revealed that amph-FITC remained largely confined to the tumour and draining inguinal and axillary LNs (Fig. 2c). The gene discussed is AMPH; the disease is neoplasm.